You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNTH Sale Disclosure
Savitz Ryan · SEC Form 4 · Filed Jul 13, 2026
Sale
Calculated transaction value
$1.04M
Savitz Ryan EVP, CFO & Cbo
DNTH
Transaction date
Jul 9, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 4 days later
DNTH daily price context
Close on/before transaction
$100.03
Jul 9, 2026
First close after public filing
$101.28
Jul 14, 2026
30-day return after filing
+10.99%
Through Aug 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,354 shares @ $100.22
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001992324-26-000008
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$3.84M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /De/ DNTH | Exercise | Jul 9, 2026 | $680.29K |
| Dianthus Therapeutics, Inc. /De/ DNTH Current | Sale | Jul 9, 2026 | $1.04M |
| Dianthus Therapeutics, Inc. /De/ DNTH | Sale | Jul 9, 2026 | $1.55M |
| Dianthus Therapeutics, Inc. /De/ DNTH | Sale | Jul 9, 2026 | $567.57K |
| Dianthus Therapeutics, Inc. /De/ DNTH | Exercise | Jul 9, 2026 | $0 |